1. Weng, Yueh-Shan, Tseng, Hong-Yu, Chen, Yen-An, Tung, Yi-Chung, Hsu, Hsin-Ling. 2019. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. In Molecular cancer, 18, 42. doi:10.1186/s12943-019-0988-0. https://pubmed.ncbi.nlm.nih.gov/30885232/
2. Deng, Mei, Xiong, Chao, He, Zhuo-Kai, Li, Wei, Qin, Jie. 2022. MCTS1 as a Novel Prognostic Biomarker and Its Correlation With Immune Infiltrates in Breast Cancer. In Frontiers in genetics, 13, 825901. doi:10.3389/fgene.2022.825901. https://pubmed.ncbi.nlm.nih.gov/35295953/
3. Tian, Chao, Zeng, Shiyan, Luo, Jing. 2020. MCTS1 Directly Binds to TWF1 and Synergistically Modulate Cyclin D1 and C-Myc Translation in Luminal A/B Breast Cancer Cells. In OncoTargets and therapy, 13, 5353-5361. doi:10.2147/OTT.S255675. https://pubmed.ncbi.nlm.nih.gov/32606753/
4. Ding, Jane, Bansal, Mohit, Cao, Yuxia, Sudarshan, Sunil, Ding, Han-Fei. . MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development. In Cancer research, 84, 4031-4048. doi:10.1158/0008-5472.CAN-24-1102. https://pubmed.ncbi.nlm.nih.gov/39240686/
智鼠故事 
